These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4553194)

  • 81. [Recent acquisitions in virological research].
    Balducci M; Verani P
    Recenti Prog Med; 1971 May; 50(5):461-92. PubMed ID: 4332188
    [No Abstract]   [Full Text] [Related]  

  • 82. Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.
    Lehner T; Wilton JM; Shillitoe EJ
    Lancet; 1975 Jul; 2(7924):60-2. PubMed ID: 49654
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines.
    Thurman GB; Ahmed A; Strong DM; Knudsen RC; Grace WR; Sell KW
    J Exp Med; 1973 Oct; 138(4):839-46. PubMed ID: 4355279
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antibodies to measles, mumps, and herpes simplex virus in cerebrospinal fluid in acute infections and postinfectious diseases of the central nervous system.
    Winchester JS; Hambling MH
    J Med Microbiol; 1972 Feb; 5(1):137-43. PubMed ID: 5022506
    [No Abstract]   [Full Text] [Related]  

  • 85. Subacute sclerosing panencephalitis after passive immunization and natural measles infection: role of antibody in persistence of measles virus.
    Rammohan KW; McFarland HF; McFarlin DE
    Neurology; 1982 Apr; 32(4):390-4. PubMed ID: 7199661
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Viral infections.
    Cesario TC; Yousefi S
    Clin Geriatr Med; 1992 Nov; 8(4):735-43. PubMed ID: 1330279
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells.
    Santoli D; Trinchieri G; Koprowski H
    J Immunol; 1978 Aug; 121(2):532-8. PubMed ID: 150448
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Interferon production, cellular and humoral immunity in splenectomized patients.
    Lanng Nielsen J; Haahr S
    Scand J Haematol; 1982 Aug; 29(2):168-74. PubMed ID: 6182609
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.
    Looney RJ; Diamond B; Holers VM; Levesque MC; Moreland L; Nahm MH; St Clair EW;
    Clin Immunol; 2007 Jun; 123(3):235-43. PubMed ID: 17329169
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunotherapy of viral infections with transfer factor.
    Mazaheri MR; Hamblin AS; Zuckerman AJ
    J Med Virol; 1977; 1(3):209-17. PubMed ID: 204742
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A Review of Viral-Related Malignancies and the Associated Imaging Findings.
    Consul N; Menias CO; Lubner MG; Katabathina VS; Chahinian RA; Mansour J; Elsayes KM
    AJR Am J Roentgenol; 2020 Jan; 214(1):W1-W10. PubMed ID: 31593515
    [No Abstract]   [Full Text] [Related]  

  • 92. [Characteristics of anti-viral immunity].
    Kosiakov PN
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Feb; 48(2):11-4. PubMed ID: 4931909
    [No Abstract]   [Full Text] [Related]  

  • 93. Viruses, neurodevelopmental disorder and childhood psychosis.
    Nunn KP; Lask B; Cohen M
    J Child Psychol Psychiatry; 1986 Jan; 27(1):55-64. PubMed ID: 2419355
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Viral mechanisms of immune evasion.
    Alcami A; Koszinowski UH
    Trends Microbiol; 2000 Sep; 8(9):410-8. PubMed ID: 10989308
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immune and autoimmune reactions in the pathogenesis of slow virus disease.
    Hotchin J
    Curr Top Microbiol Immunol; 1967; 40():33-43. PubMed ID: 6059312
    [No Abstract]   [Full Text] [Related]  

  • 96. Oncogenic viruses, cancer biology, and innate immunity.
    White MC; Wu X; Damania B
    Curr Opin Immunol; 2022 Oct; 78():102253. PubMed ID: 36240666
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of immunosuppression in lymphoma formation.
    Penn I
    Springer Semin Immunopathol; 1998; 20(3-4):343-55. PubMed ID: 9870250
    [No Abstract]   [Full Text] [Related]  

  • 98. Cell mediated immunity in virus infections.
    Doherty PC
    Biosci Rep; 1997 Aug; 17(4):367-87. PubMed ID: 9367053
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Analysis of the clinical trial results of the flavonoid effects on some cellular immunity indicators in children and adults.
    Beketova G; Kuznetsova L; Grynevych O; Broun T; Momotiuk L; Motuzka O; Yashchenko L
    Pol Merkur Lekarski; 2021 Feb; 49(289):44-53. PubMed ID: 33713093
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Immune serum in the prophylaxis and treatment of virus diseases.
    LEVINSON SO; SHAUGHNESSY HJ
    Med Clin North Am; 1946 Jan; 30():61-73. PubMed ID: 21010147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.